Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers

Date
2021-11-23
Authors
Sirpu Natesh, Nagabhishek
White, Brianna M.
Bennett, Maia M. C.
Uz, Metin
Rathnam Kalari Kandy, Rakhee
Batra, Surinder
Rachagani, Satyanarayana
Major Professor
Advisor
Committee Member
Journal Title
Journal ISSN
Volume Title
Publisher
MDPI
Altmetrics
Authors
Research Projects
Organizational Units
Neuroscience
Organizational Unit
Ames Laboratory
Organizational Unit
Journal Issue
Series
Department
Chemical and Biological EngineeringMaterials Science and EngineeringNeuroscienceAmes Laboratory
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with high mortality, poor prognosis, and palliative treatments, due to the rapid upregulation of alternative compensatory pathways and desmoplastic reaction. miRNAs, small non-coding RNAs, have been recently identified as key players regulating cancer pathogenesis. Dysregulated miRNAs are associated with molecular pathways involved in tumor development, metastasis, and chemoresistance in PDAC, as well as other cancers. Targeted treatment strategies that alter miRNA levels in cancers have promising potential as therapeutic interventions. miRNA-345 (miR-345) plays a critical role in tumor suppression and is differentially expressed in various cancers, including pancreatic cancer (PC). The underlying mechanism(s) and delivery strategies of miR-345 have been investigated by us previously. Here, we summarize the potential therapeutic roles of miR-345 in different cancers, with emphasis on PDAC, for miRNA drug discovery, development, status, and implications. Further, we focus on miRNA nanodelivery system(s), based on different materials and nanoformulations, specifically for the delivery of miR-345.
Comments
This article is published as Natesh, Nagabhishek Sirpu, Brianna M. White, Maia Bennett, Metin Uz, Rakhee Rathnam Kalari Kandy, Surinder K. Batra, Surya K. Mallapragada, and Satyanarayana Rachagani. "Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers." Pharmaceutics 13, no. 12 (2021): 1987. DOI: 10.3390/pharmaceutics13121987. Copyright 2021 by the authors. Attribution 4.0 International (CC BY 4.0). Posted with permission.
Description
Keywords
PDAC, miR-345, miRNA nanodelivery
Citation
DOI
Collections